BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 403504)

  • 1. [Complications arising in hemolytic disease of newborn].
    Maskiewicz W; Ornat K; Ziemniak J
    Pediatr Pol; 1977 Mar; 52(3):293-8. PubMed ID: 403504
    [No Abstract]   [Full Text] [Related]  

  • 2. [Late anemia in hemolytic disease of the newborn].
    Molaro GL; Vazzoler G
    Minerva Pediatr; 1966 Nov; 18(35):2072-7. PubMed ID: 4969530
    [No Abstract]   [Full Text] [Related]  

  • 3. [Behavior of erythrocytic and plasmatic neuraminic acid in newborn infants with Rh and ABO hemolytic disease].
    Ambrosioni G; Serritelli G
    Clin Pediatr (Bologna); 1968 Sep; 50(9):540-6. PubMed ID: 4973613
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood lactate dehydrogenase activity in newborns with hemolytic disease due to Rh and ABO-incompatibility].
    Dobronravov AV
    Vopr Okhr Materin Det; 1969 Jan; 14(1):33-8. PubMed ID: 4976718
    [No Abstract]   [Full Text] [Related]  

  • 5. [Practical and clinical problems in hemolytic disease of the newborn].
    Kaloud H
    Wien Med Wochenschr; 1966 Nov; 116(46):975-80. PubMed ID: 4965842
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypoglycemia in hemolytic disease of the newborn].
    Leopardi F; D'Avanzo M
    Pediatria (Napoli); 1970; 78(1):63-74. PubMed ID: 4987178
    [No Abstract]   [Full Text] [Related]  

  • 7. [Erythrocyte sedimentation and clinical findings in newborn infants with hemolytic disease].
    Maszkiewicz W; Irzyńska D
    Pediatr Pol; 1977 May; 52(5):503-6. PubMed ID: 407544
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thin layer chromatography of the total lipids in hemolytic disease of the newborn (Rh and ABO). 1. Principal lipid fractions in the plasma and quantitative determination of lipemia].
    Salvioli GP; Allocca G; Ambrosioni G
    Clin Pediatr (Bologna); 1968 Oct; 50(10):645-53. PubMed ID: 4988028
    [No Abstract]   [Full Text] [Related]  

  • 9. [The dynamics of serum-free amino acid concentration in newborn infants with hemolytic disease].
    Egorova AI; Aksenova NM
    Vopr Okhr Materin Det; 1972 Jan; 17(1):87-8. PubMed ID: 4629897
    [No Abstract]   [Full Text] [Related]  

  • 10. [Thin-layer chromatography of total lipids in hemolytic disease of the newborn (Rh and ABO). 3. Principal lipid fractions in the erythrocyte in toto in the erythrocytic stroma].
    Salvioli GP; Ambrosioni G; Allocca G
    Clin Pediatr (Bologna); 1968 Dec; 50(12):926-31. PubMed ID: 4979138
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hemolytic disease of the newborn caused by fetomaternal incompatibility].
    Escandé CA; Lorenzo y de Ibarreta J; Temesio N; Garófalo O; Pérez-Scremini A; Vila-Vidal P; Vilanova R
    Arch Pediatr Urug; 1965 Jul; 36(7):455-68. PubMed ID: 4954973
    [No Abstract]   [Full Text] [Related]  

  • 12. [Materno-fetal incompatibility in the ABO system as a factor of protection against hemolytic disease caused by Rh incompatibility].
    Mollica F
    Minerva Pediatr; 1967 Mar; 19(13):610-1. PubMed ID: 4963996
    [No Abstract]   [Full Text] [Related]  

  • 13. [Aspect of reticulocytes and erythroblasts studied by fluorescence microscopy in hemolytic disease of the newborn caused by autoantibodies and isoantibodies. II. Reticulocytes in hemolytic disease of the newborn caused by Rh and ABO incompatibility].
    Lombardo G; Infortuna M; Franchina A
    Boll Soc Ital Biol Sper; 1975 Dec; 51(24):2005-11. PubMed ID: 821502
    [No Abstract]   [Full Text] [Related]  

  • 14. [Problems of children with hemolytic disease of the newborn, caused by Rh and ABO blood group incompatibility, treated by exchange transfusion].
    Osuch-Jaczewska R; Boruta E; Baumert M; Paprotny M; Jerzykiewicz-Dziuba K; Giec-Fuglewicz G
    Acta Haematol Pol; 1988; 19(3-4):153-9. PubMed ID: 3150889
    [No Abstract]   [Full Text] [Related]  

  • 15. [Characteristics of determination of the blood groups and Rh factors after exchange transfusions in newborn infants].
    Avdeeva RA; Kopp VD; Vasil'eva AF
    Probl Gematol Pereliv Krovi; 1978 Feb; 23(2):7-12. PubMed ID: 417341
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunization anemia in infants with a history of hemolytic disease of the newborn].
    Maszkiewicz W; Prusek W; Rotter A; Ziemniak J; Irzyńska-Fonfara D; Zylka W; Lindner-Czygrinow I
    Pediatr Pol; 1974 Jan; 49(1):9-17. PubMed ID: 4204510
    [No Abstract]   [Full Text] [Related]  

  • 17. [Remote after-effects of hemolytic diseases in newborn, caused by the ABO- and Rh-incompatibility in the blood of mother and fetus].
    Nersisian VM
    Zh Eksp Klin Med; 1969; 9(5):82-5. PubMed ID: 4988140
    [No Abstract]   [Full Text] [Related]  

  • 18. SEROLOGICAL ASPECT OF HEMOLYTIC DISEASE OF NEWBORN.
    ISLAMI ZS
    Va Med Mon (1918); 1963 Oct; 90():530. PubMed ID: 14069389
    [No Abstract]   [Full Text] [Related]  

  • 19. [Personal experience with the use of light in paraphysiological neonatal hyperbilirubinemia and hemolytic disease of the newborn due to Rh and ABO factors].
    Salvioli GP; Dallacasa P
    Minerva Pediatr; 1972 Feb; 24(3):113-23. PubMed ID: 4622393
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hemolytic disease of the newborn with ABO incompatibities, its immediate and late sequelae].
    Frishman MM; Smirnova GD; Pavliuk GA
    Pediatr Akus Ginekol; 1976; (4):17-8. PubMed ID: 825817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.